• Economy
  • Investing
  • Editor’s Pick
  • Stock
Keep Over Tradings
Stock

US stocks open flat after Trump raises global tariffs to 15%

by February 23, 2026
by February 23, 2026

US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court ruling that struck down his earlier “reciprocal” tariff framework.

The S&P 500 hovered around the flatline during the session, while the Dow Jones Industrial Average and the Nasdaq Composite also traded with minimal movement.

Investors appeared cautious as they assessed the implications of the new tariff regime for inflation, growth, and corporate earnings.

The move followed a weekend announcement in which Trump said he would raise the global tariff rate from 10% to 15%, adding that the new duties would take effect immediately.

However, it remained unclear whether formal documentation had been signed to confirm the timing.

Tariff announcement and legal backdrop

Trump’s decision came shortly after the Supreme Court of the United States struck down a broad set of his earlier trade measures.

In a post on Truth Social, Trump said: “I, as President of the United States of America, will be, effective immediately, raising the 10% Worldwide Tariff on Countries, many of which have been ‘ripping’ the U.S. off for decades, without retribution (until I came along!), to the fully allowed, and legally tested, 15% level.”

He also warned that additional levies could be introduced in the coming months, raising concerns that trade policy uncertainty may persist.

The tariffs were imposed under Section 122 of the Trade Act of 1974, which allows the president to levy duties for up to 150 days before congressional approval is required.

Market participants said this legal framework could continue to generate volatility.

Europe voices concern

Officials in Europe expressed unease over the tariff increase, warning that transatlantic trade relations could be affected.

The European Commission said in a statement on Saturday that “the current situation is not conducive to delivering ‘fair, balanced, and mutually beneficial’ transatlantic trade and investment” and called for “full clarity” from the US government.

The statement reflected growing worries that escalating trade barriers could undermine existing agreements and disrupt supply chains.

Gold rallies, Bitcoin slides

Commodities and digital assets reflected growing risk aversion following the tariff announcement.

Gold prices jumped as investors sought safety. Spot gold advanced more than 1%, while gold futures climbed around 2%, driven by concerns over inflation and global growth prospects.

Bitcoin, meanwhile, came under pressure. The cryptocurrency fell below $65,000 at one point before recovering above $66,000.

It remained down about 2% on the day, extending a recent sell-off as risk appetite weakened.

The divergence between gold and Bitcoin highlighted a broader shift toward traditional safe-haven assets.

Volatility follows choppy session

Wall Street entered Monday’s session following a volatile end to last week.

On Friday, stocks initially rallied after the Supreme Court ruling, as investors anticipated a possible easing of trade tensions and potential refunds for companies affected by earlier tariffs.

However, gains were uneven and fragile, reflecting uncertainty over how the administration would respond.

Trump’s weekend announcement quickly erased hopes that trade risks would recede.

Market participants said policy unpredictability remains a key overhang for equities.

Movers on Monday

Several individual stocks recorded sharp moves during the session.

Shares of Arcellx surged 78% after Gilead Sciences agreed to acquire the company for $7.8 billion.

The deal includes $115 per share in cash at closing and a contingent value right of $5 per share.

Arcellx focuses on immunotherapies for cancer and other incurable diseases, and the transaction is expected to close in the second quarter.

Novo Nordisk shares fell 14% after its weight-loss drug CagriSema failed to match results from a rival treatment developed by Eli Lilly and Company.

Lilly’s shares rose nearly 3% following the trial results.

Domino’s Pizza gained 4% after reporting US fourth-quarter sales growth of 3.7%, exceeding a 3.1% estimate compiled by FactSet.

Revenue also beat expectations, coming in at $1.54 billion versus a $1.52 billion forecast.

The post US stocks open flat after Trump raises global tariffs to 15% appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Almirall profit quadruples in 2025 as dermatology fuels growth push
next post
US stocks open flat after Trump raises global tariffs to 15%

Related Posts

Vanda stock’s explosive rally may be more hype...

February 23, 2026

Why is Nvidia stock soaring before Q4 earnings?...

February 23, 2026

Why Tesla stock is down over 2% on...

February 23, 2026

We predicted Blue Owl stock price crash: what’s...

February 23, 2026

We predicted Blue Owl stock price crash: what’s...

February 23, 2026

Merck creates separate oncology arm ahead of Keytruda...

February 23, 2026

Merck creates separate oncology arm ahead of Keytruda...

February 23, 2026

Royal Bank of Canada stock double-tops ahead of...

February 23, 2026

Royal Bank of Canada stock double-tops ahead of...

February 23, 2026

Eli Lilly bets on multi-dose Zepbound pen in...

February 23, 2026

Recent Posts

  • Moralizing Markets: Vatican Bank Wades into Faith-Based Indexing
  • Vanda stock’s explosive rally may be more hype than substance
  • Why is Nvidia stock soaring before Q4 earnings? Here’s $65.9B reason
  • Why Tesla stock is down over 2% on Monday
  • We predicted Blue Owl stock price crash: what’s next?

    Master Your Money – Sign Up for Our Financial Education Newsletter!


    Ready to take your financial knowledge to the next level? Our newsletter delivers easy-to-understand guides, expert advice, and actionable tips straight to your inbox. Whether you're saving for a dream vacation or planning for retirement, we’ve got you covered. Sign up today and start your journey to financial freedom!

    Recent Posts

    • Moralizing Markets: Vatican Bank Wades into Faith-Based Indexing

      February 23, 2026
    • Vanda stock’s explosive rally may be more hype than substance

      February 23, 2026
    • Why is Nvidia stock soaring before Q4 earnings? Here’s $65.9B reason

      February 23, 2026
    • Why Tesla stock is down over 2% on Monday

      February 23, 2026
    • We predicted Blue Owl stock price crash: what’s next?

      February 23, 2026
    • We predicted Blue Owl stock price crash: what’s next?

      February 23, 2026

    Editors’ Picks

    • 1

      Ormat Signs 150 Megawatt Geothermal Deal to Power Google Data Centers in Nevada

      February 19, 2026
    • 2

      Christopher Aaron: Gold, Silver Going Higher — This Cycle Ends in Mania

      February 19, 2026
    • 3

      Sranan Provides Update on Late Filing of Financial Statements

      February 19, 2026
    • 4

      Precious Metals Price Update: Gold, Silver, PGMs Face Another Bumpy Week

      February 19, 2026
    • 5

      Genesis Moves to Acquire Magnetic in US$450 Million Deal, Boosts Laverton Growth Strategy

      February 19, 2026
    • 6

      Amended Announcement Visual Copper Mineralisation at Chester

      February 19, 2026
    • 7

      NevGold Drills 8.51 g/t Oxide AuEq Over 10.6 MetersWithin 2.32 g/t Oxide AuEq Over 86.8 Meters ; Discovers High-Grade Oxide Gold-Antimony “Armory Fault” Structure At Bullet Zone

      February 18, 2026

    Categories

    • Economy (14)
    • Editor’s Pick (4)
    • Investing (67)
    • Stock (28)
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: keepovertrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 keepovertrading.com | All Rights Reserved

    Keep Over Tradings
    • Economy
    • Investing
    • Editor’s Pick
    • Stock
    Keep Over Tradings
    • Economy
    • Investing
    • Editor’s Pick
    • Stock
    Disclaimer: keepovertrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 keepovertrading.com | All Rights Reserved

    Read alsox

    We predicted Blue Owl stock price crash:...

    February 23, 2026

    Royal Bank of Canada stock double-tops ahead...

    February 23, 2026

    We predicted Blue Owl stock price crash:...

    February 23, 2026